AcuityMD Inc.
AcuityMD provides a MedTech Intelligence Platform for medical technology companies to identify markets, find opportunities, and increase revenue.
Secondary Market Price
Secondary Market Price
How AcuityMD Inc. Measures Up
To help you manage your AcuityMD Inc. equity, Prospect has run the company through our machine learning model.
Prospect Rating
TBD
We are currently evaluating AcuityMD Inc. and are still gathering the necessary data for our rating. Check back soon for our projection on what the company could be worth in four years.
Exit Risk
TBD
We are still gathering data on AcuityMD Inc. to train our machine learning model. Check back soon for our exit risk rating for AcuityMD Inc.!
Funding Stage
Series B
For a potential employee, AcuityMD's Series B status signifies that the company has a validated product and is now focused on expansion. This stage offers a sweet spot between the high-risk, early-startup phase and a large, established corporation, presenting significant opportunities for personal and professional growth.
Secondary Market Price Chart
The secondary market prices for AcuityMD Inc. shown here are a limited preview. Create a free account to access real-time secondary market prices
Sign up to Unlock the Latest DataData will be available soon.
Sign up to receive notifications when it is available.
Prospect Projected Future AcuityMD Inc. Prices
Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for AcuityMD Inc.'s equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.
Powerful tools to earn more from your equity
Company Description
AcuityMD Inc. is a software development company that provides a commercial intelligence platform for the medical technology (MedTech) industry. The platform is used by more than 300 MedTech companies, including six of the top ten, to help their commercial teams identify target markets, find new opportunities, and grow revenue. It works by combining external market data with a company's internal sales data to provide insights into product performance and market penetration. Founded in 2018 and headquartered in Boston, MA, the company has grown to over 180 employees and serves a customer base ranging from pre-commercial startups to global enterprises.
In mid-2024, AcuityMD secured a $45 million Series B funding round led by ICONIQ Growth, aimed at accelerating its product development and market expansion. The company has recently focused on integrating artificial intelligence into its platform, launching new tools that include Forecasting, AI Next Best Actions, and AI Voice Notes. These features were developed in collaboration with alpha partners, such as Corza Biosurgery, and were introduced at the company's Flywheel 2025 user conference. Future plans include hosting its Flywheel 2026 event in Philadelphia and continuing to expand its platform's capabilities to support MedTech commercial teams.
- ICONIQ
- Redpoint
- Benchmark
- StepStone Group
- Atreides Management
- Co-Founder, CEO Michael Monovoukas
- Co-Founder, CTO Robert Coe
- Co-Founder, VP, Customer Experience Lee Smith
Peer Group Comparison
Vs Peer Group of >$4B Startups
Frequently Asked Questions
Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.
Is AcuityMD Inc. worth joining?
Deciding whether to join AcuityMD Inc. requires a deep look into its growth potential, financial health, and the value of its equity offer. Platforms like Prospect can help you evaluate the opportunity by providing independent, data-driven projections on what your equity could be worth.
What should I do with my AcuityMD Inc. stock?
Managing your AcuityMD Inc. stock involves making strategic decisions about exercising options and planning for taxes to maximize your potential returns. Using a service like Prospect can provide you with personalized, tax-optimized strategies and predictive models to help you make informed choices.
Can you sell AcuityMD Inc. stock?
As a private company, selling AcuityMD Inc. stock is generally restricted and can typically only happen during specific liquidity events like a tender offer or acquisition. When such opportunities arise, tools from platforms like Prospect can help you decide how much to sell and which shares are most tax-optimal.
How can I find the value of my AcuityMD Inc. stock?
The value of stock in a private company like AcuityMD Inc. is determined by its 409A valuation and the price set during its most recent funding round. To get a forward-looking estimate, you can use platforms like Prospect, which provide independent projections on what your equity is likely to be worth based on data-driven models.
What is AcuityMD Inc.'s equity worth?
The precise worth of AcuityMD Inc.'s equity is not public and depends on factors like company performance, valuation, and future liquidity events. You can use specialized tools like the ones offered by Prospect to model different scenarios and forecast the potential value of your holdings.
What is AcuityMD Inc.'s stock ticker symbol?
AcuityMD Inc. does not have a stock ticker symbol because it is a private company and its shares are not traded on a public stock exchange. Ticker symbols are only assigned to companies once they complete an Initial Public Offering (IPO).
Can I buy or sell AcuityMD Inc. stock?
As AcuityMD Inc. is a private company, its stock is not available for purchase on public markets and buying opportunities are typically limited to accredited investors during specific funding rounds. Selling shares is also restricted for employees, usually only possible during company-approved liquidity events.
What is the criteria to buy or invest in AcuityMD Inc. stock?
Investing in a private company like AcuityMD Inc. is typically restricted to accredited investors who meet specific income or net worth requirements as defined by financial regulators. Employees may also receive equity as part of their compensation package, which is another way to hold stock in the company.
